PFIZER INC Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Pfizer Inc quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2010 to Q4 2023.
  • Pfizer Inc Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $1.74B, a 12.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $1.74B +$197M +12.8% Dec 31, 2023 10-K 2024-02-22
Q4 2022 $1.54B +$79M +5.4% Dec 31, 2022 10-K 2024-02-22
Q4 2021 $1.46B -$124M -7.82% Dec 31, 2021 10-K 2023-02-23
Q4 2020 $1.59B +$60M +3.93% Dec 31, 2020 10-K 2022-02-24
Q4 2019 $1.53B -$542M -26.2% Dec 31, 2019 10-K 2021-02-25
Q4 2018 $2.07B -$135M -6.13% Dec 31, 2018 10-K 2020-02-27
Q4 2017 $2.2B +$254M +13% Dec 31, 2017 10-K 2019-02-28
Q4 2016 $1.95B -$80M -3.94% Dec 31, 2016 10-K 2018-02-22
Q4 2015 $2.03B +$414M +25.6% Dec 31, 2015 10-K 2017-02-23
Q4 2014 $1.62B +$327M +25.4% Dec 31, 2014 10-K 2016-02-29
Q4 2013 $1.29B +$255M +24.7% Dec 31, 2013 10-K 2015-02-27
Q4 2012 $1.03B -$168M -14% Dec 31, 2012 10-K 2014-02-28
Q4 2011 $1.2B +$307M +34.3% Dec 31, 2011 10-K 2013-02-28
Q4 2010 $894M Dec 31, 2010 10-K 2012-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.